Delivery Order SPE2DR25D1109-SPE2DR26FFK3J
Award Date 1/8/26
Potential Completion Date 1/9/26
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13,355.87 delivery order to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, with an ultimate completion date of August 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems...
- The Defense Logistics Agency awarded a delivery order valued at $1,838.12 to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, with an ultimate completion date of June 3, 2025. This non-set-aside, firm fixed price delivery order represents a competitive award to the pharmaceutical distributor for medical supply provision supporting federal healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical and healthcare solutions...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,429.76 for Cathflo Activase 2 mg vials on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product will be delivered to...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $18,377.82 for Cathflo Activase 2 mg vials, with a completion date of August 13, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $1,696.80 to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, a pharmaceutical product used in medical treatment. The award was made on November 12, 2025, with an ultimate completion date of November 13, 2025, under a firm fixed-price delivery order contract with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,357.44 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials. This firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025, and represents a non-set-aside competitive award. The product will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors and...
- The Defense Logistics Agency awarded a $4,321.45 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, with an ultimate completion date of December 15, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cathflo Activase 2 mg vials. The contract has a ceiling value of $1,282.38 and is a firm fixed price, non-set-aside delivery order with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,058.66 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials, with an ultimate completion date of December 30, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,306.32 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials. This firm fixed-price delivery order was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical procurement, which falls under the...